Diabetes
Recent studies from Switzerland and Japan add new data to diabetes research
Published in Obesity and Diabetes Week, May 15th, 2006
Study 1: Older age at time of reaching end-stage renal disease in type 1 diabetes mellitus may significantly impact the demand for renal grafts.
According to a study from Switzerland, "Diabetes mellitus (DM) type 1 is an important contributor to end-stage renal disease (ESRD) among younger transplant recipients. However, little is known about the changes in epidemiological characteristics of this population. Especially, time to reach ESRD may have changed in type 1 diabetic patients referred for transplantation, resulting in higher age at time of grafting. Such time trends may...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Genetics & Genomics
Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity - Obesity & Cardiology
High leptin levels in obese may be beneficial to coronary endothelium - Obesity & Cardiology
PPAR-agonist improves left ventricular function in obese dyslipidemic mice - Obesity & Metabolic Syndrome
Obesity and leukocyte count link was dependent on the presence of metabolic syndrome - Obesity Pathogenesis
ENPP1, an insulin receptor inhibitor, is a genetic link between obesity and diabetes - Angiology
Endothelial cell progenitors display differential healing activities - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
